AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
At the 184-year-old Cleveland Plain Dealer, a top editor’s push to let AI draft news articles is boosting traffic — and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results